デフォルト表紙
市場調査レポート
商品コード
1429521

インターベンショナルオンコロジーデバイスの世界市場レポート 2024年

Interventional Oncology Devices Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
インターベンショナルオンコロジーデバイスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

インターベンショナルオンコロジーデバイスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.7%の年間複合成長率(CAGR)で32億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、高齢者人口の増加、低侵襲手術(MIS)への選好の高まり、研究開発支出の増大、ヘルスケア支出の増加、新興経済国の高い潜在力、経済成長などの要因によるものと考えられます。がんや慢性疾患の罹患率の増加。予測期間中に予想される注目すべき動向としては、高度な画像誘導腫瘍治療装置の開発への注力、革新的な装置を作成するための人工知能(AI)の利用、腫瘍治療を強化するための新しい革新的な塞栓装置の開発、ロボット工学の使用の重視などが挙げられます。テクノロジーを活用し、他の企業や調査機関と協力して製品開発とイノベーションを加速します。

インターベンショナルオンコロジーデバイス市場は、民間と政府の両方の資金源からの資金の利用可能性によって成長を遂げてきました。がん調査、特に治療に使用される機器に対する資金の増加は、早期発見の進歩と生存率の向上に貢献します。主要な非政府がん調査資金提供者である米国がん協会は、2021年に3億8,426万2,652ドルの助成金を630のプロジェクトに割り当てました。注目すべき資金調達の例としては、前立腺がん患者向けの生体吸収性ポリマースペーサーバルーンを開発しているイスラエルの企業であるBioProtect Ltd.が挙げられ、同社はベンチャー投資家からシリーズD株式融資で1,300万米ドルを受け取りました。さらに、初の拡張現実誘導アブレーションシステムであるEndosightは、民間団体から資金の20%を確保しました。これらの資金調達イニシアチブは革新的なテクノロジーとデバイスの開発を促進し、それによってインターベンショナルオンコロジーデバイス市場を推進します。

インターベンショナルオンコロジーデバイス市場は、がんの罹患率の高さにより成長の見込みがあります。制御されていない細胞増殖を特徴とするがんは、診断、治療、管理に使用されるインターベンショナルオンコロジーデバイスに対する大きな需要を生み出します。たとえば、Macmillan Cancer Supportは、2020年のがん患者数は300万人と推定し、2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると予測しています。このがん有病率の高まりは、インターベンショナルオンコロジーデバイス市場の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のインターベンショナルオンコロジーデバイス市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 塞栓装置
  • アブレーション装置
  • サポートデバイス
  • 世界のインターベンショナルオンコロジーデバイス市場、施術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 熱腫瘍アブレーション
  • 非熱的腫瘍アブレーション
  • 経カテーテル動脈化学塞栓術(TACE)
  • 経カテーテル動脈放射線塞栓術(TARE)または選択的内部放射線治療(SIRT)
  • 経カテーテル動脈塞栓術(TAE)またはブランド塞栓術
  • 世界のインターベンショナルオンコロジーデバイス市場、がんタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 肝臓がん
  • 腎臓がん
  • 肺がん
  • 骨がん
  • その他のがんタイプ

第7章 地域および国の分析

  • 世界のインターベンショナルオンコロジーデバイス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のインターベンショナルオンコロジーデバイス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • インターベンショナルオンコロジーデバイス市場の競合情勢
  • インターベンショナルオンコロジーデバイス市場の企業プロファイル
    • Boston Scientific Corporation
    • Terumo Corporation
    • Siemens Healthineers
    • Sirtex Medical Limited
    • Merit Medical Systems, Inc.

第31章 その他の大手および革新的な企業

  • Merck &Co. Inc.
  • CVS Health
  • Henlius
  • Viant Medical
  • AngioDynamics Inc.
  • Pfizer
  • Steris Applied Sterilization Technologies
  • Co, Dr.Reddy's
  • International SOS
  • CapeRay
  • Innovent Biologics
  • Novartis AG
  • Consonance
  • ABLbio
  • Adimmune

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14492

Interventional oncology devices are utilized in the diagnosis and treatment of cancer through minimally invasive techniques and advanced imaging technology.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.35 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the historical period can be attributed to factors such as an aging population pool, an increase in cancer prevalence, an uptick in pharmaceutical research and development (R&D) expenditure, increased healthcare expenditure, and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.25 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to factors such as the increasing older population, a growing preference towards minimally invasive surgeries (MIS), escalating research and development spending, a rise in healthcare expenditure, high potential in emerging economies, and an increasing prevalence of cancer and chronic diseases. Notable trends expected in the forecast period include a focus on developing advanced image-guided oncology devices, the utilization of artificial intelligence (AI) to create innovative devices, the development of new and innovative embolic devices to enhance oncology procedures, an emphasis on using robotics technology, and collaboration with other companies and research institutes to accelerate product development and innovation.

The interventional oncology devices market has experienced growth driven by the availability of funding from both private and government sources. Increased funding in cancer research, especially for devices used in treatments, contributes to advancements in early detection and improved survival rates. In 2021, the American Cancer Society, a major non-governmental cancer research funder, allocated $384,262,652 in grants to 630 projects. Notable funding examples include BioProtect Ltd., an Israeli company developing bioabsorbable polymer spacer balloons for prostate cancer patients, which received $13 million in Series D equity financing from venture investors. Additionally, Endosight, the first augmented-reality-guided ablative system, secured 20% of its funding from private organizations. These funding initiatives foster the development of innovative technologies and devices, thereby propelling the interventional oncology devices market.

The interventional oncology devices market is poised for growth due to the high prevalence of cancer. Cancer, characterized by uncontrolled cell growth, creates a substantial demand for interventional oncology devices used in diagnosis, treatment, and management. For instance, Macmillan Cancer Support estimated 3 million people with cancer in 2020, projecting an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This heightened prevalence of cancer is a significant driver for the interventional oncology devices market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market report are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Merit Medical Systems, Inc., Merck & Co. Inc., CVS Health, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, CoDr.Reddys, International SOS, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic PLC, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc., Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2023. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Embolization Devices; Ablation Devices; Support Devices
  • 2) By procedure: Thermal Tumor Ablation; Non-Thermal Tumor Ablation; Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Radioembolization (TARE); Selective Internal Radiation Therapy (SIRT); Transcatheter Arterial Embolization (TAE); Bland Embolization
  • 3) By Cancer Type: Liver Cancer; Kidney Cancer; Lung Cancer; Bone Cancer; Other Cancer Types
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Merit Medical Systems, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Interventional Oncology Devices Market Size and Growth

  • 5.1. Global Interventional Oncology Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Interventional Oncology Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Interventional Oncology Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Interventional Oncology Devices Market Segmentation

  • 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolization Devices
  • Ablation Devices
  • Support Devices
  • 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE) or Bland Embolization
  • 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer Types

7. Interventional Oncology Devices Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

  • 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Interventional Oncology Devices Market

  • 9.1. China Interventional Oncology Devices Market Overview
  • 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Interventional Oncology Devices Market

  • 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Interventional Oncology Devices Market

  • 11.1. Japan Interventional Oncology Devices Market Overview
  • 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Interventional Oncology Devices Market

  • 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Interventional Oncology Devices Market

  • 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Interventional Oncology Devices Market

  • 14.1. South Korea Interventional Oncology Devices Market Overview
  • 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Interventional Oncology Devices Market

  • 15.1. Western Europe Interventional Oncology Devices Market Overview
  • 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Interventional Oncology Devices Market

  • 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Interventional Oncology Devices Market

  • 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Interventional Oncology Devices Market

  • 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Interventional Oncology Devices Market

  • 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Interventional Oncology Devices Market

  • 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

  • 21.1. Eastern Europe Interventional Oncology Devices Market Overview
  • 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Interventional Oncology Devices Market

  • 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Interventional Oncology Devices Market

  • 23.1. North America Interventional Oncology Devices Market Overview
  • 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Interventional Oncology Devices Market

  • 24.1. USA Interventional Oncology Devices Market Overview
  • 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Interventional Oncology Devices Market

  • 25.1. Canada Interventional Oncology Devices Market Overview
  • 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Interventional Oncology Devices Market

  • 26.1. South America Interventional Oncology Devices Market Overview
  • 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Interventional Oncology Devices Market

  • 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Interventional Oncology Devices Market

  • 28.1. Middle East Interventional Oncology Devices Market Overview
  • 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Interventional Oncology Devices Market

  • 29.1. Africa Interventional Oncology Devices Market Overview
  • 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Devices Market Competitive Landscape
  • 30.2. Interventional Oncology Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Terumo Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sirtex Medical Limited
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merit Medical Systems, Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Interventional Oncology Devices Market Other Major And Innovative Companies

  • 31.1. Merck & Co. Inc.
  • 31.2. CVS Health
  • 31.3. Henlius
  • 31.4. Viant Medical
  • 31.5. AngioDynamics Inc.
  • 31.6. Pfizer
  • 31.7. Steris Applied Sterilization Technologies
  • 31.8. Co, Dr.Reddy's
  • 31.9. International SOS
  • 31.10. CapeRay
  • 31.11. Innovent Biologics
  • 31.12. Novartis AG
  • 31.13. Consonance
  • 31.14. ABLbio
  • 31.15. Adimmune

32. Global Interventional Oncology Devices Market Competitive Benchmarking

33. Global Interventional Oncology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market Future Outlook and Potential Analysis

  • 35.1 Interventional Oncology Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer